Role of cardiovascular biomarkers for the assessment of mitral stenosis and its complications

Badoz M., Arrigob M., Iung B., Amioglu G., YILMAZ M. B., Meneveau N., ...Daha Fazla

EUROPEAN JOURNAL OF INTERNAL MEDICINE, cilt.34, ss.58-62, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.ejim.2016.05.008
  • Dergi Adı: EUROPEAN JOURNAL OF INTERNAL MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.58-62
  • Anahtar Kelimeler: Mitral stenosis, Pulmonary hypertension, Biomarker, BNP, MR-proANP, sCD146, NATRIURETIC PEPTIDE, B-TYPE, HEART-FAILURE, ECHOCARDIOGRAPHIC-ASSESSMENT, LEVELS CORRELATE, ATRIAL, RECOMMENDATIONS, SEVERITY, SYMPTOMS, PROBNP
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background: Mitral stenosis (MS) may cause progressive dyspnea on exertion, pulmonary hypertension (PH), atrial fibrillation and right ventricular (RV) failure. Patients with MS presenting with change in dyspnea severity often require a complete cardiologic assessment, but the use of biomarkers may be an alternative for the initial assessment of MS and its complications. The aim of this study was to evaluate the role of several cardiovascular biomarkers for this purpose.